Member Info for VikR

I didn’t realise being a 7 figure investor precluded one from using this forum.

As for following use your own initiative to make your independent decisions

I don’t think this is a ‘2 bit board’ I have picked many useful snippets of information from here

As for profits to good causes…100% advocate this whether you were being sarcastic or otherwise

Back to the topic in hand - SVNS STRONG buy and hold. Commercial traction and talks behind the scenes continue with multiple big Pharma - exciting times

Big buyers putting there savings into this, beats leaving it in the banks to get some sizeable return on your holdings

Happy holding astute investors

I’m playing around with circ 7 figures of £’s between them so it gets distributed between those very shares you mentioned. Whilst what I say may come across as a ramp I genuinely believe in the shares I invest in and do my due diligence into the fundamentals. I practice what I preach and actually buy in sizeable amounts rather then contributing +ve or -ve from the sidelines with no vested interest

On that note stay vested astute investors

I’m already maxed out I wish it was mine although I’m due £5k loose change soon which is going straight back in here

Yes agreed there is little resistance on the way up to 30p. It will then settle above there as that has been its normal MINIMUM baseline since 2017 as per the historical chart data prior 2023.

At these levels my opinion is everyone should be circulating their savings/profits/earnings into this. When the comm deal or next progression RNS lands this will surge unilaterally so far up you will not have a chance to get back in.

Between this and FAB fusion antibodies nearly up 6 figures but first target will be 7 figures on the MEGA RNS drop before I consider any top slicing

Stay vested astute investors

They always keep the discussions confidential with NDAs on any new or ongoing discussions with pharma/CRO makes for a better play this way as each one doesn’t want to be left out and there becomes a competitive bidding war. Telling the public of who these companies are actually does more harm then good in getting maximum premium for the products on offer

With the assets in situ and the strong deal closers at the board level this is determined for success.

As a pharmacist myself for 18 years and now a clinical prescriber issuing 100’s of drugs/ month in this therapeutic area and also a visiting lecturer for the last 10 years I research these things in MEGA depth before making any investment decisions. I stand by the science proudly and the novel compounds currently being manufactured. I don’t know yet how well the in-vivo studies for the PTSD drugs will work but irrespective of this there is too much in the treasure chest for this to fail.

We will be prescribing the drugs SVNS have discovered in the next 5 years and we will make positive improvements in society and sobriety where needed. This has a VERY strong commercial business case but is also a very ethical and rewarding share to embark upon

Ignore the noise and stay vested astute investors

Decided to make an evidence based decision today and top up some more just under 50k shares. Average holding is around the 8’s but

this is one of a few of a once in a lifetime opportunity

Happy holding astute investors

Recycling all my profits from others into this one every time it goes back down. One of the very few shares that shoots up rapidly on sentiment and fundamentals when the news begins to drop which is imminent. In fact when it reverts upwards so fast very difficult to get back in so easier to hold and let the Hamak team do there job

Good luck ALTHs and any newbie investors - a great addition to your portfolio

Astute investors

heed the advice of the knowledgeable posters in this group and do not be tempted to sell to get a lower entry. Be part of the holders that benefit from the huge rise up which will most likely gap up in a single session with multiple positive RNSs due to land any time from now until December 2025

Good luck ALTHs and any newbie investors looking to make maximal profits and watch UK biotech pioneer the antibody arena with its multiple innovate scientific tech.

What a great mid-week insight on that podcast,

excellent explanation quantified with objective data and factual information

onwards and upwards we go

Being the summer vacation this share seems to have escaped the attention of the investor community. With strong news imminent and a breakout to the upside due what a great top up opportunity. I keep on recycling my profits from others into this over the last few days whilst it has circulated at the current price.

Good luck ALTHs and any newbie investors looking to make significant returns

Luckily topped up yesterday and sold a few from GDR so glad I did before this RNS. 3 robust candidates identified for the massive growing mental health patient population. Serotenergic, dopimanergic and noradrenergic neural pathways activity found from these in-vitro studies are the same pathways utilised by all the existing major drugs to treat depression/anxiety/ psychiatric disorders etc. With a lot of these existing meds now off patent something new and tweaked to the market with a comprehensive evidence base will attract every single Pharma out there.

This and FAB fusion antibodies too strongest and recommended holdings to any potential investors looking for high long term returns. Nothing guaranteed in this life but as good as your going to get

Stay vested astute investors

The next catalyst RNS will catapult the SP straight to 30p from here and then some. Very confident hold for now and will try and move some more funds around to add to the few million shares I have in situ.

Good to see Prof Buick at the Immuno-Oncology Summit in Philadelphia for the next 3 days displaying the posters on Optimal to US investor associates

Stay vested astute investors

One to be in for over the weekend. Some healthy retrace and consolidation before the next wave up gives further buying opportunity.

Excellent responses to the Q&A published today which is a welcome change from prior generic responses. With this much confidence they can now afford to give more conviction in there statements

Happy loading investors old and new

Could be a competitor CRO or pharma buyer to coincide with the rights to patent now granted as this would have been pre requisite to any sensible offers coming to the table. Big talks for commercialisation were already happening in the background as already alluded to by Mr Kinkaid at the investor meet and subsequent updates. The patent grant has now just expedited these conversations to amalgamating into something tangible. DYOR

I sold on the way down on the last trading update at a loss which mentioned of winding down the company if agreements cannot be reached. As a clinical prescriber sometimes seeing IBD patients I personally don’t think there is much commercial traction in their platform hence the struggle thus far. If they do pull through though then best of luck to ALTHs who have held out. At the time I took my money out and put it into FAB fusion antibodies what a great decision has already doubled and looking to rip higher on some imminent news

Good luck whatever your decision may be and I hope you all remain prosperous

Now we are firmly on the radar there are some international pharma buyers looking to take out the business and put in an offer. I sincerely hope it reflects the true value of the platforms they have and gives massive shareholder value. Our CEO Mr Kinkaid has experience of doing the big deals so I am confident he will do the right thing as he has done thus far

Well done to everyone who has invested here, you are an astute trader

Technicals showing the upside potential by the Chartists

https://x.com/share_talk/status/1953770847212040253?s=46